Literature DB >> 12007739

Mechanisms of lipoapoptosis: implications for human heart disease.

Laura L Listenberger1, Jean E Schaffer.   

Abstract

Accumulation of long-chain fatty acids in the heart has been proposed to play a role in the development of heart failure and diabetic cardiomyopathy. Several animal models with increased cardiomyocyte lipid accumulation suggest a link between the accumulation of lipid, cardiomyocyte cell death and the development of cardiomyopathy. In this review, we discuss the mechanism through which fatty acid accumulation may contribute to the development or progression of heart failure by initiation of apoptotic cell death. Long-chain saturated fatty acids induce apoptosis through a mechanism involving the generation of reactive intermediates. Reactive intermediate production occurs in concert with de novo ceramide synthesis, but ceramide production is not required for cell death. Cardiomyocyte dysfunction and death from reactive intermediates generated by long-chain saturated fatty acids may contribute to the pathogenesis of human heart disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007739     DOI: 10.1016/s1050-1738(02)00152-4

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  43 in total

Review 1.  SLipid-induced cell dysfunction and cell death: lessons from yeast.

Authors:  Sepp D Kohlwein; Julia Petschnigg
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

2.  TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway.

Authors:  Joel D Schilling; Heather M Machkovech; Li He; Abhinav Diwan; Jean E Schaffer
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

Review 3.  Fatty heart, cardiac damage, and inflammation.

Authors:  Maria A Guzzardi; Patricia Iozzo
Journal:  Rev Diabet Stud       Date:  2011-11-10

4.  Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels.

Authors:  Tinghuai Wu; Masashi Fujihara; Jane Tian; Miroslava Jovanovic; Celene Grayson; Marisol Cano; Peter Gehlbach; Philippe Margaron; James T Handa
Journal:  J Neurochem       Date:  2010-07-27       Impact factor: 5.372

5.  Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

Authors:  Chia-Ying Liu; David A Bluemke; Gary Gerstenblith; Stefan L Zimmerman; Ji Li; Hong Zhu; Shenghan Lai; Hong Lai
Journal:  Int J Cardiol       Date:  2014-01-24       Impact factor: 4.164

6.  Fat and cardiotoxicity in hereditary pulmonary hypertension.

Authors:  Rubin M Tuder; Jeffrey C Robinson; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

7.  Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.

Authors:  Harmeet Malhi; Fernando J Barreyro; Hajime Isomoto; Steven F Bronk; Gregory J Gores
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

Review 8.  Cardiomyocyte apoptosis in animal models of obesity.

Authors:  Premal S Trivedi; Lili A Barouch
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

9.  Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.

Authors:  Ni-Huiping Son; Tae-Sik Park; Haruyo Yamashita; Masayoshi Yokoyama; Lesley A Huggins; Kazue Okajima; Shunichi Homma; Matthias J Szabolcs; Li-Shin Huang; Ira J Goldberg
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.

Authors:  Aiwei Yao-Borengasser; Negah Rassouli; Vijayalakshmi Varma; Angela M Bodles; Neda Rasouli; Resat Unal; Bounleut Phanavanh; Gouri Ranganathan; Robert E McGehee; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-08-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.